SecBot SecBot
SC 14D-9/A ·Filed Oct 14, 2026

ACVA

ACV Auctions Inc.
NEUTRAL
Impact 4/10
Horizondays Processed12d 8h ago SEC0001193125-26-421067
Notable filing: SC 14D-9/A
Actionable Insight • Neutral

With HSR clearance secured, the remaining conditions are largely procedural. The offer is expected to close shortly — monitor for the final tender results and the subsequent short-form merger. No further regulatory hurdles remain.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d ⚠ clustered
ACVA ▲ 0.00% at T+5d
NEUTRAL call 0.00% · α vs SPY -0.45% · entry $10.50 → $10.50
Next anchor: T+20d in 16d
Entry = T+0 close
Oct 14, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.28%
$10.50
settled 11d ago
T+5d
0.00%
call 0.00% · α -0.45%
$10.50
settled 5d ago
T+20d
Pending
in 16d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

ACV Auctions filed Amendment No. 4 to its Schedule 14D-9, confirming that the HSR Act waiting period for Copart's $10.50/share all-cash tender offer expired on October 13, 2026, satisfying a key condition to the offer. The board continues to recommend the offer, and with antitrust clearance now obtained, the deal is on track to close. The filing is purely procedural — no change in recommendation, price, or deal terms.

Key Facts

  • HSR Act waiting period expired at 11:59 p.m. ET on October 13, 2026, satisfying the HSR clearance condition.
  • Copart's offer is $10.50 per share in cash, all-cash consideration.
  • Parent voluntarily withdrew and refiled its HSR notification on September 28, 2026, to allow additional FTC/Antitrust Division review time.
  • The board's recommendation remains unchanged — ACV Auctions continues to recommend shareholders tender shares.
  • As of the original expiration date (September 30, 2026), ~81.3M shares (47.78%) were tendered; as of the extended deadline (October 7, 2026), ~90.2M shares (52.84%) were tendered, exceeding the minimum condition.

Financial Impact

Deal value ~$2.2B based on ~210M fully diluted shares at $10.50/share (approximate). No change in offer price or terms.

deal completion probabilityregulatory risk

Risk Factors

  • Shareholder lawsuits alleging disclosure deficiencies in the Schedule 14D-9 are pending and could delay or alter terms.
  • Any material adverse change or failure to satisfy remaining closing conditions could still derail the deal.

Investment Themes

Software & IT

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 14D-9/A Filing (Primary)0001193125-26-421067
Document: 0001193125-26-421067-index-headers.html0001193125-26-421067
Document: 0001193125-26-421067-index.html0001193125-26-421067
Document: 0001193125-26-421067.txt0001193125-26-421067
17 reports for ACVA
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 5 of 6 best @ T+1▲ +6.82%Jun 11, 2026
Filters
Rows
Reports for ACVA — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
8-K
MIXED ★ 9/10
$10.50awaiting T+20——
Oct 16, 2026
10d ago
SC 14D-9/A
NEUTRAL ★ 5/10
$10.50awaiting T+20——
Oct 16, 2026
10d ago
25-NSE
MIXED ★ 8/10
$10.50awaiting T+20——
Oct 16, 2026
10d ago
SC TO-T/A
BULLISH ★ 8/10
$10.50awaiting T+20——
Oct 14, 2026
12d ago
SC 14D-9/A
NEUTRAL ★ 4/10
$10.50awaiting T+20——
Oct 14, 2026
12d ago
SC TO-T/A
BULLISH ★ 7/10
$10.50awaiting T+20——
Oct 8, 2026
18d ago
SC 14D-9/A
NEUTRAL ★ 5/10
$10.44awaiting T+20——
Oct 8, 2026
18d ago
SC TO-T/A
BULLISH ★ 7/10
$10.44awaiting T+20——
Oct 1, 2026
25d ago
SC 14D-9/A
NEUTRAL ★ 5/10
$10.45awaiting T+20——
Oct 1, 2026
25d ago
SC TO-T/A
BEARISH ★ 7/10
$10.45awaiting T+20——
Showing 10 of 17

US Market Status

Market Closed — Opens Tue (16h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 14, 2026